Contrast Media pp 121-123 | Cite as

Pheochromocytoma and Contrast Media

  • Judith A. W. Webb
Part of the Medical Radiology book series (MEDRAD)


Patients with catecholamine-producing tumors (pheochromocytomas and paragangliomas) do not need any special preparation before they receive non-ionic iodine-based contrast medium or any gadolinium-based contrast medium intravenously. It is recommended that such patients should receive oral α- and β-adrenergic blocking drugs before they are given non-ionic iodine-based contrast media intra-arterially.


Contrast Medium Adrenal Mass Plasma Noradrenaline Plasma Catecholamine Catecholamine Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Alfidi RJ, Gill WM, Klein HJ (1969) Arteriography of adrenal neoplasms. Am J Roentgenol 106:635–641CrossRefGoogle Scholar
  2. Baid SK, Lai EW, Wesley RA et al (2009) Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. Ann Intern Med 150:27–32PubMedCentralPubMedCrossRefGoogle Scholar
  3. Bessell-Browne R, O’Malley ME (2006) CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of non-ionic contrast material. Am J Roentgenol 188:970–974CrossRefGoogle Scholar
  4. Blake MA, Krishnamoorthy SK, Boland GW et al (2003) Low density pheochromocytoma on CT: a mimicker of adrenal adenoma. Am J Roentgenol 181:1663–1668CrossRefGoogle Scholar
  5. Bouloux P-MG, Fakeeh M (1995) Investigation of pheochromocytoma. Clin Endocrinol 43:657–664CrossRefGoogle Scholar
  6. Francis I, Gross MD, Shapiro B et al (1992) Integrated imaging of adrenal disease. Radiology 184:1–13PubMedGoogle Scholar
  7. Gold RE, Wisinger BM, Geraci AR, Heinz LM (1972) Hypertensive crisis as a result of adrenal venography in a patient with pheochromocytoma. Radiology 102:579–580PubMedGoogle Scholar
  8. Grumbach MM, Biller BM, Braunstein GD et al (2003) Management of clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424–429PubMedCrossRefGoogle Scholar
  9. Ilias I, Pacak K (2004) Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89:479–491PubMedCrossRefGoogle Scholar
  10. Kirchin MA, Runge VM (2003) Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imag 14:426–435CrossRefGoogle Scholar
  11. Korobkin M (2000) CT characterisation of adrenal masses: the time has come. Radiology 217:629–632PubMedCrossRefGoogle Scholar
  12. Lenders JWM, Pacak K, McClellan MM et al (2002) Biochemical diagnosis of pheochromocytoma. Which test is best? JAMA 287:1427–1434PubMedCrossRefGoogle Scholar
  13. Meaney TF, Buonocore E (1966) Selective arteriography as a localizing and provocative test in the diagnosis of pheochromocytoma. Radiology 87:309–314PubMedGoogle Scholar
  14. Mukherjee JJ, Peppercorn PD, Reznek RH et al (1997) Pheochromocytoma: effect of non-ionic contrast medium in CT on circulating catecholamine levels. Radiology 202:227–231PubMedGoogle Scholar
  15. Patel V, Kaltsas G, Nageh T et al (1995) 123I-MIBG imaging in chromaffin tumours: interference due to intravenous phenoxybenzamine. J Endocrinol 144(Suppl):P194Google Scholar
  16. Raisanen J, Shapiro B, Glazer GM et al (1984) Plasma catecholamines in pheochromocytoma. Effect of urographic contrast media. Am J Roentgenol 143:43–46CrossRefGoogle Scholar
  17. Rossi P, Young IS, Parke WF (1968) Techniques, usefulness and hazards of arteriography of pheochromocytoma. JAMA 205:75–81CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Consultant Emeritus, Diagnostic Radiology DepartmentSt, Bartholomew’s Hospital, University of LondonLondonUK

Personalised recommendations